Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I — Class I drug recall D-0228-2017
Terminated recall by Town and Country Compounding and Consultation Services, reported 2016-12-28, distributed in FL, MA, NJ, NY. Non-Sterility; microbial contamination identified as Bacillus circulans
| Recall number | D-0228-2017 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Town and Country Compounding and Consultation Services, Ridgewood, NJ, United States |
| Recall initiated | 2016-08-01 |
| Classified | 2016-12-22 |
| Reported by FDA | 2016-12-28 |
| Terminated | 2019-10-08 |
| Distributed | FL, MA, NJ, NY |
| Countries outside the US | CA |
| Quantity | 12 vials |
| Reason classes | microbial contamination, sterility |
| Expiration dates | 2017-01-13 |
Product
Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx, Town and Country Compounding and Consultation Services, Ridgewood, NJ 074502
Reason for recall
Non-Sterility; microbial contamination identified as Bacillus circulans
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0228-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.